Trends Affecting the Medical Technology Industry Stephen J. Ubl President and CEO, AdvaMed March 27, 2008.

Slides:



Advertisements
Similar presentations
Health Doing Business with the World - The new role of corporate leadership in global development Geneva, September 2007 World Business Council for Sustainable.
Advertisements

Objectives Know why companies use distribution channels and understand the functions that these channels perform. Learn how channel members interact and.
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Building a New Payment System: Stakeholder Perspectives on Principles and Elements Robert L. Broadway, FHFMA VP of Corporate Strategy, Bethesda Healthcare.
Copyright © 2008 Pearson Addison-Wesley. All rights reserved. Chapter 17 China and India in the World Economy.
Chapter 11 An Introduction to Open Economy Macroeconomics.
21 Health Care McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
The New Economy in Indianapolis The New Economy in Indianapolis Rob Atkinson Vice President and Director, Technology and New Economy Project Progressive.
Its Not All About PhRMA: NIHs Role in R&D David B. Moore Senior Associate Vice President Office of Government Relations January 26, 2006.
Deborah Bachrach, JD Bachrach Health Strategies LLC November 11, 2010.
Medicare Reform Exhibit 12 New benefit administered exclusively by private insurers New benefit administered exclusively by private insurers New income-related.
Health Care Spending Growth
Governor Jim Doyles Roadmap to Universal Access to Health Care for all Wisconsinites Even During Difficult Economic Times Jason A. Helgerson Wisconsin.
Medicare’s Role Medicare covers 47 million Medicare beneficiaries
Paul B. Ginsburg, Ph.D. Presentation to The Rising Costs of Health Care: What Can be Done, Alliance for Health Reform, June 12, 2012 Policy Support for.
National Health Policy Conference February 12, 2007 Washington, D.C. Kim Belshe.
The Impact of Drug Benefit Caps Geoffrey Joyce, PhD.
TABLE OF CONTENTS CHAPTER 1.0: Trends in the Overall Health Care Market Chart 1.1: Total National Health Expenditures, 1980 – 2005 Chart 1.2: Percent Change.
Oregon Health Care Reform "Letting Go of the Rope"
Exhibit 1. National Health Expenditures per Capita, 1980–2007
Multinational Comparisons of Health Systems Data, 2009 Gerard F. Anderson and Patricia Markovich Johns Hopkins University November 2009 Support for this.
THE COMMONWEALTH FUND Figure 1. Health Care Opinion Leaders Agree on the Need for a Public–Private Entity to Coordinate Quality Source: Commonwealth Fund.
State & Local Governments
THE COMMONWEALTH FUND 1 Bending the Curve: Options for Achieving Savings and Improving Value in Health Spending Cathy Schoen Senior Vice President The.
Regional Policy EUROPEAN COMMISSION Regions delivering Lisbon through Cohesion Policy Press Briefing by Regional Policy Commissioner Prof. Danuta.
State Budget Issues Across the Nation: How does North Carolina Compare? North Carolina Office of State Budget and Management Annual Conference October.
The Vermont Health Care Commission 2005 Future Directions for Health Care Reform in Vermont Kenneth E. Thorpe, Ph.D. Robert W. Woodruff Professor and Chair.
Can Information Technology Transform Health Care? The RAND Study of Potential Costs and Benefits of Electronic Medical Record Systems Roger S. Taylor MD,
Problems of the American Health Care System
Current Types of Payments in the U.S. Healthcare System
Trade Promotion Management Study Summary Charts
Historical Perspective on British Columbias Credit Rating Presentation to Financial Management Institute June 18, 2008.
Introduction When you choose a restaurant for a meal, are you concerned with: The price of the meal How long you have to wait to be seated The quality.
Russias Image Among Foreign Investors Key findings from survey and focus group research conducted April – May 2007 by HART RESEARCH P e t e r D ASSOTESCIA.
IHPA and the National Efficient Price (NEP) Independent Hospital Pricing Authority.
Andrea Mariottini Riello Gas Boilers Division
Uncertainty and Volatility in Global and Domestic Markets Robert B. Engel President & Chief Executive Officer December 6, 2010.
For the Healthcare Provider
CHAPTER 1: UNDERSTANDING THE FINANCIAL PLANNING PROCESS.
THE COMMONWEALTH FUND 1 Benefit Design for Public Health Insurance Plan Offered in Insurance Exchange Current Medicare benefits* New Public Health Insurance.
THE COMMONWEALTH FUND Figure 1. Three of Five Health Care Opinion Leaders Feel that Mixed Private-Public Group Insurance Is an Effective Approach to Achieving.
THE COMMONWEALTH FUND Figure 1. More Than Two-Thirds of Opinion Leaders Say Current Payment System Is Not Effective at Encouraging High Quality of Care.
THE COMMONWEALTH FUND Figure 1. 96% of leaders do not think 21% of GDP is an appropriate target for health care spending in Source: Commonwealth.
Putting Children in the Electoral Spotlight April 2012 Prepared for Voices for America’s Children Civic Engagement Project.
Industry Report Photonics 2013 Common Market Analysis.
1 Revenue Update Jody M. Wagner Secretary of Finance Commonwealth of Virginia
11 Welcome To Understanding Save the Children Insert date and location.
State Fiscal Outlook: Minnesota and the Nation One Minnesota January 9, 2013 Scott Pattison Executive Director National Association of State Budget Officers.
State Fiscal Conditions: Temporary Downturn or New Normal? MAGNY March 15, 2013 New York Scott Pattison Executive Director National Association of State.
 The Patient Protection and Affordable Care Act : How will ACA Impact Small Business? Sponsors: St. Tammany Democratic Parish Executive Committee (DPEC)
59%23% 4% Figure 1. Distribution of Health Insurance Coverage, New York State, 2004– million people Note: Data include all persons below age 65.
The EMR Puzzle – Putting the Pieces Together March 10, 2015.
Prospects for Federal Health Legislation in the 111 th Congress For the 2009 Health Care Forecast Conference Michael Hash Health Policy Alternatives, Inc.
Affordability: The New Imperative Northeastern University Open Classroom October 27, 2010 Andrew Dreyfus President & CEO Blue Cross Blue Shield of Massachusetts.
A Roadmap for Achievable Health Care Reform Karen Ignagni President and CEO America’s Health Insurance Plans November 13, 2007.
Issues and Challenges Facing Medicare Mark L. Hayes.
Steve Ubl President and CEO, AdvaMed Advocating For Reasonable Regulation March 29, 2006.
November 04, 2008 The Price of Medical Technology: The Industry Perspective David H. Nexon Senior Executive Vice President.
CPR Principles:  Put People First  Be Visionary & Innovative  Be Accountable & Efficient  Be Performance Driven  Save Taxpayer Dollars Health and.
Academy Health Annual Meeting, Orlando, June 2007 What Accounts for the Rise in Medicare Spending? Kenneth E. Thorpe, Ph.D. Robert W. Woodruff Professor.
The future of Medicare fee-for- service Mark E. Miller, Ph.D. Executive Director Medicare Payment Advisory Commission October 16, 2006.
About AdvaMed World’s largest medical technology association 1,600+ member companies and subsidiaries Members produce 90% of sales in domestic market,
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress 1 How to Implement a Private Payer Reimbursement Strategy Barbara Grenell.
Transforming Maryland’s Health Care & Engaging Communities Charles County Forum on Maryland’s All Payer System Transformation Carmela Coyle President &
March 28, 2007 Medical Device Regulatory, Reimbursement and Compliance Congress Steve Ubl President and CEO AdvaMed.
What HIT Policy Changes Will Mean for MedTech October 22, 2004 Blair Childs Executive Vice President, Strategic Planning & Implementation.
Health Reform: An Overview Unit 4 Seminar. The Decision The opinions spanned 193 pages, upholding the individual insurance mandate while reflecting a.
Implantable Medical Devices: Accelerating Standards Development to Streamline Regulation Joshua Price | August 2,
Presentation transcript:

Trends Affecting the Medical Technology Industry Stephen J. Ubl President and CEO, AdvaMed March 27, 2008

About AdvaMed Worlds largest medical technology association 1,600+ member companies and subsidiaries Members produce 90% of sales in domestic market, 50% of sales in global market 70%+ of member companies have less than $30 million in annual revenue 65 staff with global expertise, bi-partisan backgrounds 45 member Board of Directors including 5 from smaller companies 2

AdvaMeds Role DesignClinicalReview Idea through FDA: 2-6 yrs CoveragePayment Coding Cov & Paymt: 0-6 Japan Canada UK Korea Germany Mexico China India France Think Tanks 3

The Policy Environment 4 Democratic Suspicion of Business Activist Congress Budget Driven Policy Health Reform Increased Oversight Critical Media

Trends Affecting the Medical Technology Industry 5

Medicare evolving into an aggressive purchaser Challenges: Movement toward pay-for-performance Commoditization via competitive bidding Greater bundling of services Trend #1

Medicare evolving into an aggressive purchaser Our Response: Ensure pay-for-performance promotes quality & efficiency, not cheapest is best approach Work for payments that reflect true cost of care Protect patient access to the most appropriate therapies Trend #1 7

Difficult environment for industry reputation Challenges: Increasingly negative press coverage Recalls raise questions of safety and efficacy Sales & marketing practices under fire Trend #2 8

Industry Favorability: Congress PHYSICIANS 9

Difficult environment for industry reputation Our Response: Proactive and positive policy proposals Build positive industry image through Value of Medical Technology program Demonstrate continued leadership on ethics and compliance Trend #2

FDA credibility under fire Challenge: FDA may become more risk adverse in reaction to media & congressional scrutiny Preemption authority questioned FDA resources vs. increasing responsibilities Trend #3 11

FDA credibility under fire Our response: Focus on appropriate MDUFMA implementation Support adequate FDA funding Defend FDA preemption authority Promote least burdensome regulatory approach (IVD proposal) Trend #3 12

Global race to the bottom Challenge: Growing interest in foreign reference pricing Proposed price-driven tendering processes Nascent regulatory and pricing systems in emerging markets Trend #4 13

Global race to the bottom Our Response: Provide evidence demonstrating how FRP is inappropriate Partner with patients, physicians & local device associations Engage early with authorities in key emerging markets (China, India) Highlight value of technology and industrys contributions to economic development Trend #4 14

Misperception: Technology Drives Health Care Costs Trend #5 Our Biggest Challenge The bulk of the long-term rise in health costs resulted from...new medical services that were made possible by technological advances... Future increases in spending could be moderated if costly new medical services were adopted more selectively...than they have in the past and if diffusion of existing costly services was slowed.

Our Response: Four-Pronged Approach 1. Medical technology reduces health care costs Testing hospitalized patients for drug-resistant infections = $8.3 billion in savings in 2005 Medical imaging to diagnose & treat stroke yields savings of $800 million per year Total knee replacements save $77,000 per patient in lifetime health care costs 16

Our Response: Four-Pronged Approach 2. Medical technology generates real economic value From 1970 to 1998, improvements to life expectancy from cardiovascular care advancements alone added $2.6 trillion per year to U.S. wealth Nearly half of GDP for this period 17

Our Response: Four-Pronged Approach 3. Focus on the root causes of cost growth Fee-for-service systems reward providers for delivering more care – not better care Lack of effective prevention measures Costs of chronic disease Inefficiency in the health care system 18

Our Response: Four-Pronged Approach 4. Quality of life improvements due to medical technology are priceless Medicare inpatient payment rates FY 2007 –Cochlear implant = $8,650 –Knee replacement = $9,281 –ICD = $28,886 19

In closing... Push for health care reform & budgetary pressures = continued spotlight on medical technologys role in health care We intend to have a seat at the table. We will fight for a health care system that provides access to quality medical care for all. Policy decisions over the next 25 months could affect the industry for the next 25 years... 20

Two roads... Static road vs. dynamic road Slowed innovation, rationed care, short-term price cuts, growing ranks of uninsured, or... Emphasis on health promotion/disease prevention, focus on quality, more efficient delivery system, quality health care for all 21

Questions? 22

Trends Affecting the Medical Technology Industry Stephen J. Ubl President and CEO, AdvaMed March 27, 2008